Elacestrant trials for ESR1 Gene Mutation

All Elacestrant trials · All ESR1 Gene Mutation trials

Phase breakdown

Recruiting trials studying Elacestrant for ESR1 Gene Mutation

• Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i.
  NCT06382948 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 104 locations
• PhII Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer (CAPELA)
  NCT07222215 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Safety of Elacestrant in ER+/HER2- and ESR1 Mutations MBC
  NCT06544577 · Phase: Not specified · Ages: 18 Years and older · Sex: Female · 1 location

Common questions

How many trials study Elacestrant for ESR1 Gene Mutation?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.